| Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy C Onal, M Reyhan, C Parlak, OC Guler, E Oymak International Journal of Gynecologic Cancer 23 (6), 2013 | 55 | 2013 |
| Prognostic value of 18F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy C Onal, OC Guler, M Reyhan, AF Yapar Gynecologic Oncology 137 (1), 40-46, 2015 | 53 | 2015 |
| Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy C Onal, G Erbay, OC Guler Journal of Magnetic Resonance Imaging 44 (4), 1010-1019, 2016 | 49 | 2016 |
| Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy C Onal, OC Guler, BA Yildirim The Breast 42, 150-156, 2018 | 48 | 2018 |
| The feasibility of prostate-specific membrane antigen positron emission tomography (PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients OC Guler, B Engels, C Onal, H Everaert, R Van den Begin, T Gevaert, ... Clinical and Translational Oncology 20, 484-490, 2018 | 46 | 2018 |
| Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy C Onal, M Reyhan, OC Guler, AF Yapar European journal of nuclear medicine and molecular imaging 41, 1336-1342, 2014 | 46 | 2014 |
| Prognostic use of pretreatment hematologic parameters in patients receiving definitive chemoradiotherapy for cervical cancer C Onal, OC Guler, BA Yildirim International Journal of Gynecologic Cancer 26 (6), 2016 | 43 | 2016 |
| The effect of androgen deprivation therapy on 68Ga-PSMA tracer uptake in non-metastatic prostate cancer patients C Onal, OC Guler, N Torun, M Reyhan, AF Yapar European Journal of Nuclear Medicine and Molecular Imaging 47, 632-641, 2020 | 41 | 2020 |
| Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy C Onal, S Sonmez, G Erbay, OC Guler, G Arslan The British journal of radiology 87 (1034), 20130617, 2014 | 38 | 2014 |
| Treatment outcomes of metastasis-directed treatment using 68Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation … P Hurmuz, C Onal, G Ozyigit, S Igdem, B Atalar, H Sayan, Z Akgun, M Kurt, ... Strahlentherapie und Onkologie 196, 1034-1043, 2020 | 37 | 2020 |
| Definitive chemoradiation therapy following surgical resection or radiosurgery plus whole-brain radiation therapy in non-small cell lung cancer patients with synchronous … C Parlak, H Mertsoylu, OC Güler, C Onal, E Topkan International Journal of Radiation Oncology* Biology* Physics 88 (4), 885-891, 2014 | 36 | 2014 |
| A multi-institutional analysis of sequential versus ‘sandwich’adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma C Onal, SY Sari, BA Yildirim, G Yavas, M Gultekin, OC Guler, S Akyurek, ... Journal of Gynecologic Oncology 30 (3), 2019 | 31 | 2019 |
| Integration of 68Ga-PSMA-PET/CT in radiotherapy planning for prostate cancer patients C Onal, N Torun, F Akyol, OC Guler, P Hurmuz, BA Yildirim, M Caglar, ... Clinical Nuclear Medicine 44 (9), e510-e516, 2019 | 30 | 2019 |
| Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases Y Ozdemir, N Torun, OC Guler, BA Yildirim, AA Besen, AG Yetisken, ... Journal of bone oncology 15, 100218, 2019 | 30 | 2019 |
| Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients C Onal, G Ozyigit, E Oymak, OC Guler, B Tilki, P Hurmuz, F Akyol European journal of nuclear medicine and molecular imaging, 1-10, 2021 | 28 | 2021 |
| Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images G Erbay, C Onal, E Karadeli, OC Guler, S Arica, Z Koc Acta Radiologica 58 (4), 481-488, 2017 | 27 | 2017 |
| Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide E Topkan, U Selek, Y Ozdemir, BA Yildirim, OC Guler, F Ciner, ... Journal of Neuro-Oncology 139, 411-419, 2018 | 26 | 2018 |
| Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients during abiraterone/enzalutamide treatment C Onal, F Kose, G Ozyigit, S Aksoy, E Oymak, S Muallaoglu, OC Guler, ... The Prostate 81 (9), 543-552, 2021 | 25 | 2021 |
| Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients C Onal, G Ozyigit, OC Guler, P Hurmuz, N Torun, M Tuncel, Y Dolek, ... Radiotherapy and Oncology 151, 222-227, 2020 | 22 | 2020 |
| Oligometastatic bone disease in castration-sensitive prostate cancer patients treated with stereotactic body radiotherapy using 68Ga-PSMA PET/CT: TROD 09-004 study C Onal, G Ozyigit, Z Akgun, B Atalar, S Igdem, E Oymak, F Agaoglu, ... Clinical nuclear medicine 46 (6), 465-470, 2021 | 21 | 2021 |
Cem ÖnalBaskent University在 baskent.edu.tr 的电子邮件经过验证
